Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Disease Progression and FLT3[original query] |
|---|
| High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine. Blood 2010 Oct 116 (15): 2752-8. Bachas Costa, Schuurhuis Gerrit Jan, Hollink Iris H I M, Kwidama Zinia J, Goemans Bianca F, Zwaan C Michel, van den Heuvel-Eibrink Marry M, de Bont Eveline S J M, Reinhardt Dirk, Creutzig Ursula, de Haas Valerie, Assaraf Yehuda G, Kaspers Gertjan J L, Cloos Jacqueli |
| Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes. Clinics (São Paulo, Brazil) 2011 66 (5): 793-9. Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal |
| Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome. American journal of hematology 2015 Apr 90 (4): 276-81. Strati Paolo, Kantarjian Hagop, Ravandi Farhad, Nazha Aziz, Borthakur Gautam, Daver Naval, Kadia Tapan, Estrov Zeev, Garcia-Manero Guillermo, Konopleva Marina, Rajkhowa Trivikram, Durand Menda, Andreeff Michael, Levis Mark, Cortes Jor |
| TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution. Blood cancer journal 2015 5 e331. Hou H-A, Chou W-C, Kuo Y-Y, Liu C-Y, Lin L-I, Tseng M-H, Chiang Y-C, Liu M-C, Liu C-W, Tang J-L, Yao M, Li C-C, Huang S-Y, Ko B-S, Hsu S-C, Chen C-Y, Lin C-T, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature. Scientific reports 2017 9 7 (1): 11148. Volpe Giacomo, Walton David S, Grainger David E, Ward Carl, Cauchy Pierre, Blakemore Daniel, Coleman Daniel J L, Cockerill Peter N, Garcia Paloma, Frampton J |
| Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype. Blood research 2018 12 53 (4): 294-298. Arandi Nargess, Ramzi Mani, Safaei Fatemeh, Monabati Ahm |
| The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population. Clinical lymphoma, myeloma & leukemia 2018 Nov . Xu Fei, Han Rong, Zhang Jian, Li Zheng, Wang Jun, Chu Xiao-Ling, Yu Jing-Qiu, Wang Chao, Tao Tao, Shen Hong-Jie, Chen Su-Ning, Wu De-Pei, Liu Song-Bai, Qiu Qiao-Cheng, Xue Sheng- |
| EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis. Urologic oncology 2019 01 37 (1): 71-77. Huang Kang-Bo, Liu Ran-Yi, Peng Qi-Hua, Li Zai-Shang, Jiang Li-Juan, Guo Sheng-Jie, Zhou Qiang-Hua, Liu Ting-Yu, Deng Chuang-Zhong, Yao Kai, Qin Zi-Ke, Liu Zhuo-Wei, Li Yong-Hong, Han Hui, Zhou Fang-Ji |
| Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia. Cancer medicine 2019 Aug . B?nescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Moldovan Valeriu G, Bogli? Alina, Benedek Istvan, Dima Delia, Cândea Marcela, Duicu Carmen, Iancu Mihae |
| Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Polish archives of internal medicine 2019 12 . Banescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Bogli? Alina, Lazar Erzsebet, Dima Delia, Macarie Ioan, Duicu Carmen, Iancu Mihae |
| Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. Cancer 2019 10 126 (2): 344-353. Zhang Chunxiao, Lam Stephen S Y, Leung Garret M K, Tsui Sze-Pui, Yang Ning, Ng Nelson K L, Ip Ho-Wan, Au Chun-Hang, Chan Tsun-Leung, Ma Edmond S K, Yip Sze-Fai, Lee Harold K K, Lau June S M, Luk Tsan-Hei, Li Wa, Kwong Yok-Lam, Leung Anskar Y |
| Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia. Haematologica 2020 Jul . Martín-Izquierdo Marta, Abáigar María, Hernández-Sánchez Jesús M, Tamborero David, López-Cadenas Félix, Ramos Fernando, Lumbreras Eva, Madinaveitia-Ochoa Andrés, Megido Marta, Labrador Jorge, Sánchez-Real Javier, Olivier Carmen, Dávila Julio, Aguilar Carlos, Rodríguez Juan N, Martín-Nuñez Guillermo, Santos-Mínguez Sandra, Miguel-García Cristina, Benito Rocío, Díez-Campelo María, Hernández-Rivas Jesús |
| Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
| Whole exome sequencing of pediatric leukemia reveals a novel InDel within FLT-3 gene in AML patient from Mizo tribal population, Northeast India. BMC genomic data 2022 3 23 (1): 23. Vanlallawma Andrew, Lallawmzuali Doris, Pautu Jeremy L, Scaria Vinod, Sivasubbu Sridhar, Kumar Nachimuthu Senth |
| Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Molecular biology reports 2023 8 . Ayad M Ali, Gaza F Sal |
| Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2024 6 . Rogério Reis, Gabriel S Müller, Mariane M Santos, Allan S Santos, Herbert Santos, Lorene S Santos, Bruno A Lopes, Soraya C Trindade, Roberto J Meyer, Songelí M Frei |
- Page last reviewed:Feb 1, 2024
- Content source: